- Your cart is empty
- Continue Shopping
PALBOXEN 125MG CAPSULE
DESCRIPTION
- Composition : Palbociclib
- Manufacturer: Everest
- Indication: Breast Cancer
- Packaging: 21 Caps
- Dosage Form: Capsule
Package
- 125mg
OVERVIEW & USAGE
Brand name – Palboxen
Generic name – Palbociclib
Manufacturer – Everest
Strength – 125mg
Dosage Form – Capsules
Composition – Palbociclib
Indication – Breast Cancer
Storage – at 20° – 25° C
Overview Of Palboxen 125mg Capsule
Palboxen 125 mg capsules is a target therapy medication that is used to treat breast cancer. The generic name of this medication is Palbociclib. It is a cyclin-dependent kinase inhibitor that showcases antineoplastic properties. It is based on a prescription and should be taken with food. Also, inform the doctor about all the necessary details regarding past medical history.
Pharmacodynamics
Palboxen 125mg is a piperazine pyridopyrimidine and is a cyclin-dependent kinase (CDK4/6) inhibitor. It functions by binding to the ATP pocket and inhibiting the cell division process. Therefore it shows anti-tumour activity by blocking the cell division of the cancerous cells. In addition, it stops the spreading of the tumours throughout the body.
Side Effects
- Diarrhea
- Vomiting
- Loss of appetite
- Extreme fatigue
- Dizziness
- Dry skin
- Rashes
- Irregular heartbeat
- Nosebleeds
- Increased bruises
- Hair loss
- Tingling of arms and feet
- Shortness of breath
Dosage
Palboxen 125 mg capsules is a prescription-based medication and it should be taken one time every day with food.
Missed dose
It is advisable to avoid missing any doses. In case you miss a dose of Palboxen consult your doctor immediately.
Overdose
In case of an overdose of Palboxen 125mg, contact your doctor or any healthcare provider and seek medical attention immediately.
Warning
- Palboxen can cause an allergic reaction in some patients thus it is important to gather complete information about the tablets before starting the treatment.
- Inform the doctor about all the prescription, and non-prescription medicines and vitamins that you take since Palboxen can interact with them and hinder their function.
- It is advisable to avoid pregnancy and breastfeeding during and 3 weeks after the last dose since Palboxen can cause harm to the fetus.
- Palboxen 125 mg capsules is a prescription-based medication that decreases fertility in male patients. Also, patients with female partners should avoid pregnancy till three months after the last dose.
- It is advisable to avoid alcohol and driving the treatment with Palboxen.
- Palboxen can often interact with some diseases like – liver and kidney impairments.
